Spore’s biomedical shake-up

Singapore's biomedical shake-up: Scientists 'must play in top league'

A*Star chief says funding changes due to shifts in strategy amid worry over jobs, institutes' fate

Mr Lim Chuan Poh said scientists in Singapore now play in a different league, and they will have to keep up, or brace themselves for change. PHOTO: ST FILE
New: Gift this subscriber-only story to your friends and family

According to A*Star, funding to the sector as a whole has gone up 8 per cent to $4 billion for 2016 to 2020, compared with the previous five-year period, although 40 per cent will be for competitive funding, up from 20 per cent before.

But the agency was silent on the extent of the latest round of cuts.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Sunday Times on March 04, 2018, with the headline Singapore's biomedical shake-up: Scientists 'must play in top league'. Subscribe